CA1263603A - Nephrological-urological medicine - Google Patents

Nephrological-urological medicine

Info

Publication number
CA1263603A
CA1263603A CA000496481A CA496481A CA1263603A CA 1263603 A CA1263603 A CA 1263603A CA 000496481 A CA000496481 A CA 000496481A CA 496481 A CA496481 A CA 496481A CA 1263603 A CA1263603 A CA 1263603A
Authority
CA
Canada
Prior art keywords
cysteine
urine
mmols
serum
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000496481A
Other languages
English (en)
French (fr)
Inventor
Hans-Joachim Dulce
Werner Stumpf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Original Assignee
Dr Madaus GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Madaus GmbH and Co filed Critical Dr Madaus GmbH and Co
Application granted granted Critical
Publication of CA1263603A publication Critical patent/CA1263603A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000496481A 1984-12-12 1985-11-28 Nephrological-urological medicine Expired CA1263603A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3445253.2 1984-12-12
DE3445253A DE3445253A1 (de) 1984-12-12 1984-12-12 Nephrologisch-urologisches arzneimittel

Publications (1)

Publication Number Publication Date
CA1263603A true CA1263603A (en) 1989-12-05

Family

ID=6252540

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000496481A Expired CA1263603A (en) 1984-12-12 1985-11-28 Nephrological-urological medicine

Country Status (5)

Country Link
US (1) US4849452A (enExample)
JP (1) JPS61140522A (enExample)
CA (1) CA1263603A (enExample)
CH (1) CH665773A5 (enExample)
DE (1) DE3445253A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445253A1 (de) * 1984-12-12 1986-06-26 Dr. Madaus & Co, 5000 Köln Nephrologisch-urologisches arzneimittel
GB2245491A (en) * 1990-06-25 1992-01-08 Medvet Science Pty Ltd Inhibition of metabolic oxalate formation
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
ITMI20032528A1 (it) * 2003-12-19 2005-06-20 Francesco Santangelo Uso di cistina o di cisteina per la prevenzione e il
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378351A (en) * 1980-07-11 1983-03-29 Vojislav Petrovich Methods of treating bacterial, viral or parasitic diseases
IT1195288B (it) * 1981-11-05 1988-10-12 Zambeletti Spa L Composizione farmaceutica per la terapia di calcolosi renale infetta
FR2521429B1 (fr) * 1982-02-15 1988-10-28 Mayoly Spindler Laboratoires Nouvelles compositions a effet antiasthenique puissant a base de sels doubles de l'acide ascorbique et d'un diacide amine
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
DE3445253A1 (de) * 1984-12-12 1986-06-26 Dr. Madaus & Co, 5000 Köln Nephrologisch-urologisches arzneimittel

Also Published As

Publication number Publication date
DE3445253A1 (de) 1986-06-26
CH665773A5 (de) 1988-06-15
US4849452A (en) 1989-07-18
DE3445253C2 (enExample) 1991-09-26
JPS61140522A (ja) 1986-06-27
JPH0149328B2 (enExample) 1989-10-24

Similar Documents

Publication Publication Date Title
CA1297034C (en) Liquid calcium supplementation from readily soluble mixtures of calciumcompound and citric acid
CA2272711C (en) Method for treating renal failure
EP0176094B1 (en) Parenteral alimentation solution
Pak et al. Enhanced calcium bioavailability from a solubilized form of calcium citrate
Riedel et al. α-Ketoglutarate application in hemodialysis patients improves amino acid metabolism
US20100008865A1 (en) Mixture of iron and copper salts masking metallic taste
KR940002661B1 (ko) 요독증 치료용 영양보충물의 제조방법
Kamel et al. Prolonged total fasting: a feast for the integrative physiologist
EP0150792A2 (de) Arzneimittel und die Verwendung schwerlöslicher Calcium- und/oder Magnesiumverbindungen zur Herstellung eines Arzneimittels
Knutsen et al. Intravenous theophylline-induced excretion of calcium, magnesium and sodium in patients with recurrent asthmatic attacks
Greenman et al. Biochemical disturbances and clinical symptoms during prolonged exchange resin therapy in congestive heart failure
US4849452A (en) Nephro-urological medicament
JP3484689B2 (ja) 微量元素製剤
Freeman-Narrod et al. Chronic toxicity of methotrexate in rats: partial to complete protection of the liver by choline: brief communication
CA1273875A (en) Antiinflammatory compositions and methods
US20120100226A1 (en) Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them
Schwille et al. Citrate and recurrent idiopathic calcium urolithiasis: a longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium-and long-term medication of male stone patients
Lennon Metabolic Acidosis: A Factor in the Pathogenesis of Azotemic Osteodystrophy?
WO1995028937A1 (en) Aqueous concentrate and process for preparing same
US4558050A (en) Treatment of metabolic disorders with dichloroacetate-thiamine preparations
US5143732A (en) Orally administered pharmaceutical agent for iron and magnesium substitutive therapy
RU2527042C1 (ru) Биологически активная добавка к пище для профилактики заболеваний остеопорозом
EP0426098B1 (de) Phosphatbinder zur oralen Verabreichung
KYLE et al. Renal response to ammonium chloride in glycosuric osteomalacia
JPH10109940A (ja) 亜鉛含有組成物

Legal Events

Date Code Title Description
MKLA Lapsed